loading

Aptevo Therapeutics Inc Borsa (APVO) Ultime notizie

pulisher
Jul 25, 2025

Aptevo Therapeutics' Equity Offering: Strategic Opportunity or Investor Warning? - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Aptevo Therapeutics Inc. Stock Analysis and ForecastMarket-crushing profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Aptevo Therapeutics' Share Resale and Its Implications for Liquidity and Shareholder Value - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Aptevo Therapeutics files to sell 8.25M shares of common stock for holders - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Aptevo Therapeutics' $8M Share and Warrant Offering: Balancing Dilution with Strategic Clinical Development - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Aptevo Therapeutics (APVO) Schedules Offering of 8.25 Million Shares - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Is Aptevo Therapeutics Inc. a good long term investmentFast-track wealth growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Aptevo Therapeutics Inc. stockHigh-profit stock alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Aptevo Therapeutics shareholders approve all proposals at annual meeting - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Aptevo Therapeutics Inc. stock a growth or value playRapid market gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Aptevo Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Will Aptevo Therapeutics Inc. stock benefit from AI tech trendsExceptional risk-adjusted gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 22, 2025

What drives Aptevo Therapeutics Inc. stock priceSky-high profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Aptevo Meets Nasdaq $2.5M Equity Requirement - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Aptevo Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionFree Elite Traders Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aptevo Therapeutics Inc. stock performs during market volatility2x 3x 5x Pick Alert - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey

Jul 11, 2025
pulisher
Jul 02, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise By Investing.com - Investing.com India

Jul 02, 2025
pulisher
Jul 01, 2025

Aptevo Therapeutics Regains Nasdaq Compliance with Equity Raise - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance - TipRanks

Jun 30, 2025
pulisher
Jun 24, 2025

Aptevo Therapeutics' Mysterious 10% Spike: What’s Behind the Surge? - AInvest

Jun 24, 2025
pulisher
Jun 23, 2025

Aptevo (APVO) appoints Baker Tilly as auditor after Moss Adams merger - Stock Titan

Jun 23, 2025
pulisher
Jun 22, 2025

Aptevo Therapeutics Plummets 18%: A Technical & Order-Flow Deep Dive - AInvest

Jun 22, 2025
pulisher
Jun 21, 2025

Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous - Benzinga

Jun 21, 2025
pulisher
Jun 20, 2025

Aptevo Therapeutics Raises $7.45M Through Stock Sale - TipRanks

Jun 20, 2025
pulisher
Jun 20, 2025

Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers - ACCESS Newswire

Jun 20, 2025
pulisher
Jun 19, 2025

Aptevo Therapeutics Surges 82% Amid No Fundamental News—What’s Driving the Spike? - AInvest

Jun 19, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):